Polyphenols could prevent SARS-CoV-2 infection by modulating the expression of miRNAs in the host cells by Milenkovic, Dragan et al.
      
      
                                                                                                 http://dx.doi.org/10.14336/AD.2021.0223      
 
*Correspondence should be addressed to: Dr. Dragan Milenkovic, Université Clermont Auvergne, INRAE, UNH, F-63000 Clermont-
Ferrand, France. Email: dmilenkovic@ucdavis.edu; Dr. Christian Heiss, Department of Clinical and Experimental Medicine, University 
of Surrey, Stag Hill, Guildford GU2 7XH, UK. Email: c.heiss@surrey.ac.uk.  
 
Copyright: © 2021 Milenkovic D et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. 
 
ISSN: 2152-5250                                                                                                                                                                                       1 





Polyphenols Could Prevent SARS-CoV-2 Infection by 
Modulating the Expression of miRNAs in the Host Cells 
 
Dragan Milenkovic1,2*, Tatjana Ruskovska3, Ana Rodriguez-Mateos4, Christian Heiss5* 
 
1Université Clermont Auvergne, INRAE, UNH, F-63000 Clermont-Ferrand, France. 2Department of Internal 
Medicine, Division of Cardiovascular Medicine, School of Medicine, University of California Davis, Davis, CA 
95616, USA. 3Faculty of Medical Sciences, Goce Delcev University, Stip, North Macedonia. 4Department of 
Clinical and Experimental Medicine, University of Surrey, UK. 5Department of Nutritional Sciences, School of 
Life Course Sciences, Faculty of Life Science and Medicine, King's College London, London, UK. 
 
  [Received January 19, 2021; Revised February 2, 2021; Accepted February 23, 2021] 
 
ABSTRACT: Coronaviruses (CoVs) are single-stranded RNA viruses which following virus attachment and 
entry into the host cell, particularly type 2 pneumocytes but also endothelial cells, release RNA into cytosol where 
it serves as a matrix for the host translation machinery to produce viral proteins. The viral RNA in cytoplasm 
can interact with host cell microRNAs which can degrade viral RNA and/or prevent viral replication. As such 
host cellular miRNAs represent key cellular mediators of antiviral defense. Polyphenols, plant food bioactives, 
exert antiviral properties, which is partially due to their capacity to modulate the expression of miRNAs.  The 
objective of this work was to assess if polyphenols can play a role in prevention of SARS-CoV-2 associated 
complications by modulating the expression of host miRNAs. To test this hypothesis, we performed literature 
search to identify miRNAs that could bind SARS-CoV-2 RNA as well as miRNAs which expression can be 
modulated by polyphenols in lung, type 2 pneumocytes or endothelial cells. We identified over 600 miRNAs that 
have capacity to bind viral RNA and 125 miRNAs which expression can be modulated by polyphenols in the cells 
of interest. We identified that there are 17 miRNAs with both the capacity to bind viral RNA and which expression 
can be modulated by polyphenols. Some of these miRNAs have been identified as having antiviral properties or 
can target genes involved in regulation of processes of viral replication, apoptosis or viral infection. Taken 
together this analysis suggests that polyphenols could modulate expression of miRNAs in alveolar and endothelial 
cells and exert antiviral capacity. 
 







Faced with the enormous health and socioeconomic 
burden of the current COVID-19 pandemic, humanity 
makes every effort to develop effective measures to deal 
with the crisis in all segments of the society. While social 
distancing plays an important role, other lifestyle factors, 
including diet, may have potential to counteract viral 
susceptibility. In terms of nutrition, in addition to pivotal 
macro- and micro-nutrients, an adequate and continuous 
intake of various bioactive compounds, including 
polyphenols, has been pointed out as a contributing factor 
in the increased resistance to viral infections [1]. 
Polyphenols are plant secondary metabolites that have 
various physiological functions in their dwelling plants. 
They are widespread in planta, with over 8000 different 
compounds described so far. Many of these compounds 
are found only in a limited number or in specific plant 
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species [2]. Only about 500 polyphenols are present in the 
human diet. They are classified as flavonoids, lignans, 
phenolic acids, stilbenes, non-phenolic metabolites and 
other polyphenols [3]. Polyphenols have been proven as 
molecules with strong in vitro free radical scavenging 
capacity. Within the cells however, they act 
predominantly by modulating the expression of numerous 
genes [4], including those that are involved in the cellular 
antioxidant protection [5]. Polyphenols or they 
metabolites bind to key proteins that are involved in 
cellular signaling [6, 7], which is one of the mechanisms 
of their action in vivo. They also modulate the level of 
cellular microRNAs (miRNAs) [8, 9], thus exerting a 
complex multi-layer regulation of cellular processes. 
Experimental studies have shown that polyphenols 
exert protective effects in respiratory infections caused by 
various pathogens [10-12], including viruses [13, 14]. The 
antiviral activity of polyphenols has been investigated in 
vitro and in animal experimental studies. For example, 
curcumin has been shown to directly inactivate influenza 
A virus, block its adsorption and inhibit its proliferation 
in vitro [15]. Curcumin increases the survival rate of mice 
infected with influenza A virus and decreases the 
production of cytokines by macrophages in vitro [16]. 
These findings pinpoint curcumin as a potentially relevant 
plant bioactive in prophylaxis of the systemic cytokine 
storm [17]. Similarly, hesperidin improves influenza A 
virus (H1N1) induced impairment of pulmonary function 
in rats by inhibiting cytokine production in pulmonary 
microvascular endothelial cells [18]. Quercetin [19] and 
flavanols [20] also exert protective antiviral effects. 
Although limited, epidemiological studies confirm the 
protective effect of polyphenols in viral infections [21]. 
Importantly, recent development of chemically modified 
epigallocatechin-3-O-gallate with improved antiviral 
efficacy against different types of viruses will 
significantly contribute to promotion of the use of 
polyphenols for prevention and treatment of viral 
infections [22]. A combination of α-glucosyl hesperidin 
and epigallocatechin gallate was shown to have capacity 
to induce loss of rotavirus structural integrity as well as 
reduced infectivity (replication in cell culture) [23]. Given 
the available data on the protective antiviral actions of 
polyphenols, there is an urgency to study their potential 
role in the context of the current COVID-19 pandemic, as 
prophylactic or therapeutic agents, or as treatment adjunct 
[24-27]. Quercetin is already included in the protocols for 
prophylaxis and early outpatient treatment for COVID-19 
(https://covid19criticalcare.com). In order to give 
valuable recommendations for further research on this 
topic, it is necessary to get a deeper understanding of the 
interactions between the SARS-CoV-2 virus and the 
polyphenol induced modulations within the host cells. 
Therefore, we hypothesize that polyphenols can play an 
important role in prevention of SARS-CoV-2 associated 
complications by modulating the expression of host 
miRNAs that play role in development of the viral 
infection. 
 
SARS-CoV-2 and the host cell 
 
Coronaviruses (CoVs) are single-stranded RNA viruses 
that infect a wide variety of animals, and also humans. In 
parallel with the efforts for development of effective 
vaccines for COVID-19, research into the pathogenesis of 
SARS-CoV-2 infection has also focused on understanding 
the mechanisms involved in viral entry and replication 
[28]. Following virus attachment and entry into the host 
cell, the viral particle is uncoated, and its positive-sense 
single-stranded RNA genome is released into cytosol 
where it serves as a matrix for the host translation 
machinery to produce viral proteins. SARS-CoV-2 RNA 
encodes four main structural proteins: spike (S), envelope 
(E), membrane (M), and nucleocapsid (N) and several 
other accessory proteins, such as 3a, 6, 7a, 7b, 8, and 10 
[29]. The spike protein enables the virus to bind to 
angiotensin-converting enzyme 2 (ACE2) on the host cell 
membrane, following which the viral genome makes its 
way inside the host cell [28]. Importantly, the spike 
protein is the key target for development of SARS-CoV-
2 vaccines [30, 31]. Since SARS-CoV-2 utilizes human 
machinery to translate its RNA after the entry into the cell, 
it could possibly impact several RNA-binding proteins 
from the host to bind the viral genome resulting in altered 
post-transcriptional regulation. 
The clinical presentation of COVID-19 varies widely, 
from asymptomatic infection to a fulminant form with 
systemic cytokine storm. SARS-CoV-2 infection that is 
localized mostly in the nose is usually asymptomatic. 
Progression of the infection to the lower respiratory tract 
is followed by onset of symptoms and worsening of the 
clinical presentation [32]. In alveoli, SARS-CoV-2 
initially attacks type 2 pneumocytes; subsequently, type 1 
pneumocytes are also affected. Although they occupy 
only a small percentage of the inner alveolar surface, type 
2 pneumocytes are present in abundance, and play a 
critical role in alveolar function by generating the alveolar 
surfactant layer and acting as progenitor cells for type 1 
pneumocytes [33]. Type 2 pneumocytes co-express 
ACE2, which is the primary cell surface receptor for 
SARS-CoV-2 and transmembrane serine protease 2 
(TMPRSS2), a serine protease that is required to complete 
the entry process. Co-expression of ACE2 and TMPRSS2 
is also found in the nasal secretory cells and absorptive 
enterocytes, which are also targeted by SARS-CoV-2 
[34]. Other receptors and proteins have also been 
proposed to act as mediators of SARS-CoV-2 entry in the 
human cells, such as sialic acid receptor, CD147, or 
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cathepsin B and L. All these molecules are also expressed 
in the endothelial cells [35], suggesting their involvement 
in the major vascular derangements in COVID-19. 
Indeed, lung autopsy specimens of patients who died from 
respiratory failure caused by SARS-CoV-2 show severe 
endothelial damage with disruption of endothelial 
membranes and presence of SARS-CoV-2 within the 
endothelial cells, which is accompanied with widespread 
vascular thrombosis, microangiopathy and occlusion of 
alveolar capillaries [36]. Infection of endothelial cells and 
endotheliitis in COVID-19, however, are not limited to 
the lungs, and have been demonstrated in different organs, 
such as kidney, liver, heart, or small intestine [37]. 
Therefore, endothelial and alveolar cells are among the 
primary targets in developing of strategies to combat 
SARS-CoV-2, including studies on polyphenols as 
potentially protective factors. 
 
Interplay between host cell miRNAs and viral RNAs 
 
Replication cycle of SARS-CoV-2 potentially exposes its 
RNA to an antiviral cellular defense that relies on the 
host’s endogenous miRNAs. These miRNAs could 
directly degrade viral RNA and/or prevent viral protein 
translation, such as has been reported for the influenza 
virus [38]. The role of host cellular miRNAs in negative 
regulation of virus replication is not surprising because 
siRNAs, which inhibit mRNA expression by comparable 
mechanism, have been shown to effectively impair virus 
replication. The first evidence that host cells might 
employ a miRNA in antiviral defense was provided by 
Lecellier et al., showing that human miR-32 restricts the 
accumulation of primate foamy virus type 1 (PFV-1) in 
human cells by targeting viral RNA transcripts [39]. 
Similarly, miR-24 and miR-93 can target vesicular 
stomatitis virus (VSV) L and P proteins [40] and miR-29a 
targets human immunodeficiency virus (HIV) Nef 
proteins [41] to inhibit replication. Therefore, the use of 
antisense oligonucleotides to block viral genome can be 
the most straightforward and easy to implement way 
towards development of new antiviral therapies. For 
example, in one study researchers developed four 
artificial miRNAs that were designed to target different 
regions of Chikungunya virus (CHIKV) genome. These 
miRNAs significantly inhibited CHIKV replication, up to 
99.8% [42]. On the other hand, miR-122 upregulates the 
replication of the HCV RNA genome, having a key role 
in promoting viral RNA stability [43]. The miRNA-based 
therapy for HCV infection is performed using an antimiR 
which was designed to bind directly to the mature strand 
of the targeted miR-122 and thus to induce a functional 
blockade. This is a great example of therapeutic miRNA 
targeting with a significant reduction in HCV titers (> 
300-fold), and without signs of a rebound even after 
discontinuation of the treatment [44]. Viral RNAs can also 
serve as miRNA sponges and reduce cellular miRNA 
levels, which in consequence can modulate the host’s 
cellular processes to facilitate viral replication or to inhibit 
the host’s antiviral responses. Regarding SARS-CoV-2, it 
has been proposed that bats, considered as its host of 
origin, have tolerance to potentially deadly viruses 
because of the specific miRNA profile [45]. 
 
miRNAs could explain diversity in response to SARS-
CoV-2 infection 
 
Numerous reports have illustrated the large diversity in 
terms of responses and clinical outcomes to SARS-CoV-
2 infection. One possible variable that has not been 
sufficiently addressed are the individual differences in 
patients’ miRNA profiles. A recent study has indeed 
suggested that SARS-CoV-2 virulence in aged patients 
may be due to a lower abundance of miRNAs, which may 
be a contributing factor in disease severity [46]. 
Moreover, in the COVID-19 pandemic, a significant 
gender disparity was evidenced with the male lethality 
higher than the female one: in Italy 17.7% vs 10.7% [47]. 
Sex chromosomes, in particular X chromosome, and sex 
hormones are key actors in these differences. 
Interestingly, a different expression in males and females 
of several miRNAs has been observed owing to sex 
hormones differences and/or localization on the X-
chromosome, which is particularly enriched for miRNAs. 
Hence, the potential role of these gender-associated 
miRNAs in immunity regulation and in modulation of 
viral receptors and co-receptors should be considered as a 
crucial factor in the observed different pathogenicity and 
lethality of COVID-19 in men and women. These 
observations suggest that the individual epigenetic 
differences in the miRNA profiles during an infection 
could affect the effectiveness of the antiviral responses 
and the disease severity. Thus, modulating or 
manipulating endogenous miRNAs to improve immunity 
and clinical outcomes in SARS-CoV-2 infection could be 
another avenue for further investigation [47]. 
 
Identification of human miRNAs that could interact 
with SARS-CoV-2 
 
Bartoszewski et al. [48] examined whether SARS-CoV-2 
could be targeted by human endogenous miRNAs. The 
coronaviruses genomes were tested against the set of 896 
confident mature human miRNA sequences that were 
obtained from the miRBase v2.21 using the RNA22 v2 
microRNA target discovery tool web server [49]. The 
authors observed that the pathogenic human 
coronaviruses could interact with host-specific miRNAs, 
disturb gene expression and consequently suppress 
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immunity or prevent activation of unfolded protein 
response (UPR)-related apoptosis. The authors focused on 
the potential role of the 28 miRNAs that were uniquely 
specific for SARS-CoV-2. The majority of these miRNAs 
are well expressed in bronchial epithelial cells, and their 
dysregulation has been reported for various human lung 
pathologies that include chronic obstructive pulmonary 
disease, cystic fibrosis, and tuberculosis. Furthermore, 
many of these miRNAs have been proposed to act as 
tumor suppressors that target apoptosis-related pathways. 
Hence, SARS-CoV-2, by its potential to reduce host’s 
miRNA pool, may promote infected cell survival and thus 
continuity of its replication cycle. The authors concluded 
that the pathogenesis of human coronavirus could involve 
modulation of host miRNA levels by acting as miRNA 
sponges to facilitate viral replication and/or to avoid 
immune responses. 
Sacar Demirci and Adan [50] performed a machine 
learning based miRNA prediction analysis for the SARS-
CoV-2 genome and identified human miRNAs that 
appeared to be able to target viral genes encoding proteins 
that are involved in viral life cycle. Among 2,654 mature 
entries of Homo sapiens in miRBase, 479 of them could 
target SARS-CoV-2 genes. The SARS-CoV-2 genes 
targeted by host-cellular miRNAs are mainly responsible 
for viral biogenesis, entrance, replication and infection. 
For instance, miR-203b-3p can target ORF1ab and 
ORF3a which result in the suppression of viral replication 
as already shown in influenza A virus [51]. let-7c-5p can 
target ORF1ab in SARS-CoV-2 while it was found to be 
involved in H1N1 influenza A suppression by targeting its 
M1 protein [52]. The presence of such miRNAs could be 
considered as a host’s innate antiviral defense mechanism. 
Srivastava et al. [53] used computational approach to 
investigate the potential binding sites of human miRNAs 
in SARS-CoV-2 genome using the Find Individual Motif 
Occurrences (FIMO), a motif-based sequence analysis 
tool [54]. They identified 22 miRNAs that could 
potentially bind throughout the length of the SARS-CoV-
2 viral genome. These results suggest that several 
important miRNAs are likely being titrated by SARS-
CoV-2 genome that could result in dysregulation of post-
transcriptional networks in the infected cells. Majority of 
the identified miRNAs were highly expressed in immune 
cells including CD8+T cells, CD4+T cells, NK cells, 
CD+14 cells and mast cells, signifying that these miRNAs 
could contribute to the progression of the viral infection 
and host immune response. The results also indicate that 
the highly confident genes targeted by these sponged 
miRNAs were enriched for functional terms including 
‘post transcriptional gene regulation’ and ‘cell to cell 
communication’ suggestive of a large-scale dysregulation 
across host’s tissues. 
Guterras et al. [55] analyzed sixty SARS-CoV-2 
genomes to identify regions that could work as miRNA 
sponges and potentially bind human miRNA. They 
searched for miRNAs that shared 100% identity of the 
8mer seed region with SARS-CoV-2 genome regions, 
both positive- and negative-sense. Among 2.654 mature 
miRNA sequences in miRBase, they identified over 1000 
miRNAs that showed 100% of similarity between their 
sequences and viral RNA. The search for miRNAs was 
then refined to identify those that interact with the SARS-
CoV-2 genome with a perfect alignment of 11 nucleotides 
encompassing the seed region. Using this approach, 34 
miRNAs for positive-sense and 45 miRNAs for negative-
sense viral RNA were identified that can strongly bind to 
certain key SARS-CoV-2 genes. Literature review 
revealed the potential of these miRNAs in the 
immunopathogenesis and potential treatment possibilities 
of COVID-19. The disruption and dysfunction of these 
miRNAs may dysregulate the immune response and 
stimulate the release of inflammatory cytokines altering 
the cellular response to viral infection. These miRNAs 
have been identified in studies related to pulmonary and 
cardiac disorders, including lung cancer, asthma, 
pneumonia, or cardiac fibrosis, among others. 
Khan et al. [56] also used bioinformatic analysis 
pipeline which allowed them to identify 106 host antiviral 
miRNAs against SARS-CoV-2. Whilst comparing these 
miRNAs with the antiviral miRNAs from VIRmiRNA 
[57], they have found three (miR-17-5p, miR-20b-5p, and 
miR-323a-5p) host miRNAs against SARS-CoV-2 which 
have experimental evidence of having antiviral roles 
during infections. Next, they performed miRNA pathway 
enrichment analysis and found that several pathways 
might be modulated by the host miRNAs to suppress the 
entry of the virus, prevent the spread of the virions, and to 
minimize the systemic symptoms resulting from the 
infection. For example, host miRNAs might have a 
probable role in blocking the entry of the virus, as they are 
found to be targeting the pathways needed for viral entry, 
such as PDGF receptor-like signaling, Arf-6 signaling, 
PI3K-Akt signaling, EGFR signaling, signaling evens 
mediated by focal adhesion kinase, CDC42 signaling, the 
EphrinB-EPHB pathway, Cadherin signaling, or RTK 
signaling. They can also block some machinery like p38 
MAPK signaling, FAK signaling, or PI3K-Akt signaling, 
which can be hijacked by viruses for their efficient 
replication, pre-mRNA processing, and translation. These 
host miRNAs might also try to reduce some host-induced 
inflammatory responses to prevent acute lung damage by 
targeting pathways such as VEGF signaling, Integrin 
signaling, TGF-beta signaling or TRAIL signaling. Some 
signaling pathways, such as CXCR4 signaling, TGF-beta 
signaling, mTOR signaling, or PI3K-Akt signaling, can 
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facilitate viral survival in infected cells by inhibiting 
apoptosis, autophagy, or early immune responses. 
Therefore, to develop effective therapeutics, there is 
a need to decipher the cellular targets in humans that 
interact with SARS-CoV-2 and result in altered functional 
outcomes. All these bioinformatic analyses discovered 
that human miRNAs harbor binding sites across the 
SARS-CoV-2 genome that could act as post-
transcriptional regulators. Therefore, miRNA regulation 
or manipulation could provide a novel basis for antiviral 
therapies. We and others have shown that miRNA 
expression profiles are often cell-type specific and differ 
between individuals, and importantly, can be affected by 
different factors such as nutrients present in our diets, 
including polyphenols. 
 
Antiviral properties of polyphenols 
 
Together with well described properties of polyphenols to 
prevent or delay development of noncommunicable 
diseases such as cardiovascular, metabolic or 
neurodegenerative disorders, studies, both in vitro and in 
vivo, have also revealed their antiviral properties either by 
entering into the defensive mechanism directly through 
interfering with the target viruses, or indirectly through 
activating the cells associated with the adaptive immune 
system [58]. Several studies have described potential 
antiviral activity of plant food bioactives against herpes 
virus, human immunodeficiency virus, influenza virus or 
hepatitis C virus [59]. In a recent review, it can be 
observed that different polyphenols, such as quercetin, 
quercetin 3-glucoside, resveratrol, rutin, kaempferol, 
catechin, epigallocatechin, epigallocatechin gallate, or 
ferulic acid derivatives can inhibit the replication of both 
influenza A and B viruses, suppress the influenza virus-
induced cell death, or inhibit viral activity in the early 
stage of flu infection [60]. These effects have been 
associated with the capacity of polyphenols to exert anti-
inflammatory and immunomodulatory effects (such as 
modulation of the expression of cytokines including IL-6, 
IL-8 and IFN-β) or capacity to modulate molecular 
pathways associated with viral infection (such as Toll-like 
receptor 7 signaling pathway, cell cycle pathway or 
autophagy related pathways). Several studies have also 
observed potential anti-Zika virus activity of polyphenols, 
such as the citrus flavanones [61, 62], flavonoids [63] or 
quercetin-3-β-O-D-glucoside [64]. Antiviral activity 
against Ebola virus has been reported for several 
polyphenols, such as quercetin [65], quercetin 3-β-O-D-
glucoside [66] or epigallocatechin-3-gallate [67]. 
Moreover, several studies have revealed potential 
antiviral effect of polyphenols against other coronaviruses 
such as Middle East respiratory syndrome-coronavirus 
(MERS-CoV). For example, experimental and 
computational study showed that flavonoids (herbacetin, 
isobavachalcone, quercetin 3-β-D-glucoside and 
helichrysetin) can block the enzymatic activity of MERS-
CoV 3CL protease which regulates replication of the 
MERS-CoV [68]. 
 
Table 1. Polyphenol-modulated miRNAs in pneumocytes, lung and endothelial cells. 
 
Cells/ Tissue Polyphenol Concentration Significantly modulated miRNAs Ref 
A549 cells Curcumin 10 - 20 μM miR-206 76 
A549 cells Curcumin 10 μM hsa-miR-330-5p; hsa-miR-331-5p; hsa-miR-
1276; hsa-miR-544a; hsa-miR-29c-5p; hsa-miR-
335-5p; hsa-miR-296-3p; hsa-miR-34a-5p; hsa-
miR-26a-1-3p; hsa-miR-190a; hsa-miR-362-3p; 
hsa-let-7f-2-3p; hsa-miR-302b-3p; hsa-miR-338-
3p; hsa-miR-455-3p; hsa-miR-29c-3p; hsa-miR-
154-3p; hsa-miR-21-3p; hsa-miR-377-5p; hsa-
miR-34c-5p; hsa-miR-1257; hsa-miR-744-3p; 
hsa-miR-502-5p; hsa-miR-33a-3p; hsa-miR-424-
3p; hsa-miR-92a-1-5p; hsa-miR-10b-3p; hsa-
miR-769-3p; hsa-miR-1179; hsa-miR-516a-3p; 
hsa-miR-148a-5p; hsa-miR-604; hsa-miR-499a-
5p; hsa-miR-1262; hsa-let-7a-3p; hsa-miR-25-5p 
77 
A549 cells Curcumin 50 - 100 μM miR-98 78 
A549 cells Curcumin 20 - 40 μM miR-21 79 
A549 cells Curcumin 15 μM miR-320; miR-26a; let-7i; miR-130a; miR-16; 
miR-125b; miR-23a; miR-27b; miR-155; miR-
625; miR-576-3p; miR-186*; miR-9*; let-7e 
80 
Rat lung Quercetin Intra-peritoneal daily injections of 






Curcumin 1 - 5 μM miR-126 81 
 Milenkovic D., et al                                                                            Polyphenols and miRNAs in COVID-19 prophylaxis 
Aging and Disease • Volume 12, Number 5, October 2021                                                                              6 
 
HUVECs Resveratrol 50 μM miR-221; miR-222 82 













Mixture of 3′MEC, 4′MEC7G and 
EC4′S, 1 μM each 
hsa-let-7a; hsa-let-7f; hsa-miR-10a; hsa-miR-
10b; hsa-miR-1290; hsa-miR-130b; hsa-miR-
134; hsa-miR-181a*; hsa-miR-221*; hsa-miR-
224; hsa-miR-30a*; hsa-miR-30c; hsa-miR-30e*; 
hsa-miR-320a; hsa-miR-320c; hsa-miR-320d; 
hsa-miR-361-5p; hsa-miR-365; hsa-miR-543; 
hsa-miR-769-5p 
84 
HUVECs Mixture A or/and 
Mixture B 
One mixture contained compounds 
present in the circulation 1–5 h 
after consumption of anthocyanin-







dissolved in the culture medium, 
the final concentrations were 0.1 
μM for anthocyanins and 0.5 μM 
for 4-hydroxybenzaldehyde. The 
other mixture contained 
metabolites present in the 
circulation for around 15 h after 
the consumption, named mix B. It 
was composed of hippuric acid, 
vanillic acid, ferulic acid and 
protocatechuic acid at final 
concentration in the culture 
medium of 2 μM, 2 μM, 1 μM and 
0.2 μM, respectively. 
Mix A/(+) TNF: hsa-let-7f; hsa-miR-126*; hsa-
miR-1260; hsa-miR-1268; hsa-miR-130a; hsa-
miR-181b; hsa-miR-1915; hsa-miR-26a; hsa-
miR-30b; hsa-miR-361-5p; hsa-miR-374a; hsa-
miR-376c; hsa-miR-455-3p; hsa-miR-99b 
Mix B/(+) TNF: hsa-let-7a; hsa-let-7f; hsa-miR-
1246; hsa-miR-125b; hsa-miR-126*; hsa-miR-
1260; hsa-miR-1275; hsa-miR-196b; hsa-miR-
216a; hsa-miR-23a; hsa-miR-374a; hsa-miR-720; 
hsa-miR-923 
Mix A+B/(+) TNF: hsa-let-7c; hsa-let-7f; hsa-
miR-1207-5p; hsa-miR-1246; hsa-miR-125a-5p; 
hsa-miR-125b; hsa-miR-1305; hsa-miR-181b; 
hsa-miR-1915; hsa-miR-361-5p; hsa-miR-572; 
hsa-miR-575; hsa-miR-638 
6 
HUVECs Curcumin 40 μM hsa-miR-4298; hsa-miR-23a; hsa-miR-423-3p; 
hsa-miR-671-5p; hsa-miR-21; hsa-miR-29b; hsa-
miR-27a; hsa-miR-491-5p; hsa-miR-1307; hsa-
miR-181a; hsa-miR-92a; hsa-miR-339-5p; hsa-
miR-25; hsa-miR-27b; hsa-miR-941; hsa-miR-
222; hsa-miR-138; hsa-miR-149; hsa-miR-1226; 
hsa-miR-3198; hsa-miR-1973; hsa-miR-665; 
hsa-miR-3127; hsa-miR-196b; hsa-miR-30e; hsa-




















10 μM let-7 88 
HUVECs 
(CRL-1730) 
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Polyphenols and miRNA expression in alveolar and 
endothelial cells 
 
Polyphenols exert beneficial effects on lung health, which 
has been demonstrated in several animal models. For 
example, prophylactic resveratrol inhalation partially 
preserves lung function in prematurely aging mice [69], 
whereas oral treatment with curcumin and resveratrol, 
individually or in combination, has beneficial effects in 
lung carcinogenesis [70]. It has also been demonstrated 
that quercetin can ameliorate lung inflammation in 
pulmonary artery hypertension, which is mediated by 
miR-204 modulation [71]. Interestingly, in vitro studies 
demonstrating beneficial effects of polyphenols in lung 
function, were performed mostly on type 2 pneumocytes. 
In the majority of these studies the A549 cell line was 
used, a human lung adenocarcinoma cell line that is 
subsequently characterized as a representative to type 2 
pneumocytes [72]. Using this cell line, for example, the 
anti-inflammatory and antioxidant effects of polyphenols 
have been demonstrated [73, 74], as well as their 




Figure 1. Venn diagram showing the overlapping between microRNAs with antiviral properties and microRNAs which 
expression can be modulated by polyphenols in type 2 pneumocytes and endothelial cells. 
Even though studies demonstrated that polyphenols 
exert their health properties through modulation of 
expression of protein-coding genes and proteins, there are 
only few of them that investigated the effects of 
polyphenols on the modulation of miRNAs in type 2 
pneumocytes. We were able to identify a total of five such 
studies [76-80], where the expression of miRNAs was 
analyzed by RT-PCR or microarray methods. The 
significantly modulated miRNAs are extracted in the 
Table 1. On the other hand, the number of in vitro studies 
on polyphenol-induced miRNA modification in 
endothelial cells is higher, and we were able to identify a 
total of ten such studies (Table 1), where the expression 
of miRNAs was also analyzed by RT-PCR or microarray 
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methods [6, 81-89]. The most commonly used model of 
endothelial cells are human umbilical vein endothelial 
cells (HUVECs), but other models of endothelial cells are 
also used such as human microvascular endothelial cells 
(HMEC-1 cell line) [81, 86, 90], or human retinal 
endothelial cells (HRECs) [87, 88]. These experimental 
studies have demonstrated beneficial effects of 
polyphenols on the endothelial function, in the first place 
in the context of the complex pathophysiology of 
atherosclerosis, but diabetic retinopathy has also been 
studied. Still, given the findings from the scanning 
electron microscopy of lung tissue obtained during 
autopsy of patients who died from COVID-19, where the 
presence of the virus in the endothelial cells is clearly 
visible [36], the above experimental data represent a 
valuable source of information that will help us to get a 
deeper insight into potential effects of dietary polyphenols 
on SARS-CoV-2 exposure. 
These studies have identified 125 different miRNAs 
differentially expressed by polyphenols in alveolar or 
endothelial cells. Few of the miRNAs have been identified 
in more than 1 study, for example, modulation of 
expression of hsa-let-7f and hsa-miR-126 have been 
observed in 4 different studies, hsa-miR-1246, hsa-miR-
125b, hsa-miR-23a and hsa-miR-361-5p in 3 studies. 
Moreover, among these miRNAs, some have been 
identified as presenting antiviral activities. We used 
VIRmiRNA [57] to obtain the list of miRNAs with 
antiviral properties, that included 148 different miRNAs. 
Comparison with 125 miRNAs identified as modulated by 
polyphenols in alveolar and endothelial cells, has 
demonstrated that 30 are in common (hsa-let-7a, hsa-let-
7c, hsa-let-7f, hsa-let-7g, hsa-miR-10a, hsa-miR-10b, 
hsa-miR-125a-5p, hsa-miR-125b, hsa-miR-126, hsa-
miR-130a, hsa-miR-138, hsa-miR-149, hsa-miR-155, 
hsa-miR-15a, hsa-miR-16, hsa-miR-181a, hsa-miR-21, 
hsa-miR-221, hsa-miR-222, hsa-miR-224, hsa-miR-25-
5p, hsa-miR-26a, hsa-miR-27b, hsa-miR-29b, hsa-miR-
30b, hsa-miR-30c, hsa-miR-491-5p, hsa-miR-92a, hsa-
miR-93, hsa-miR-98) (Fig. 1). Among these common 
miRNAs is miR-221 which has been identified as 
presenting antiviral ability against respiratory syncytial 
virus in bronchial epithelial cells [91]. Regarding hsa-
miR-125b, its antiviral activities were described for 
human papillomavirus and respiratory syndrome [92, 93]. 
Taken together this analysis suggests that polyphenols 
could modulate expression of miRNAs in alveolar and 
endothelial cells and exert antiviral capacity. 
 
Modulation of miRNAs by polyphenols related to 
SARS-CoV-2 
 
Our next step was to compare the list of human miRNAs 
that may interact with SARS-CoV-2 genome with the 
miRNAs which expression can be affected by 
polyphenols in alveolar and/or endothelial cells. We 
identified 644 miRNAs from the literature that can 
interact with SARS-CoV-2 genome (based on the 
publications of Bartoszewski et al. [48], Sacar Demirci 
and Adan [50], Srivastava et al. [53], Guterres et al. [55], 
and Khan et al. [56]) and 125 miRNAs which expression 
can be modulated by polyphenols. Comparison of the 2 
lists revealed 17 miRNAs in common: hsa-let-7a-3p, hsa-
miR-25-5p, hsa-miR-1246, hsa-miR-125a-5p, hsa-miR-
1262, hsa-miR-1290, hsa-miR-148a-5p, hsa-miR-154-3p, 
hsa-miR-21-3p, hsa-miR-320c, hsa-miR-335-5p, hsa-
miR-34a-5p, hsa-miR-377-5p, hsa-miR-455-3p, hsa-
miR-499a-5p, hsa-miR-544a and hsa-miR-744-3p. This 
analysis suggests that polyphenols could modulate 
miRNA expression of host cells and potentially improve 
outcome upon SARS-CoV-2 exposure. 
Among the miRNAs in common is hsa-miR-1246. It 
has been observed that this miRNA has homologous 
sequence to ACE2, which plays role in integration with 
the virus and mediates viral entry. One recent study 
reported higher expression of ACE2 in the small airway 
epithelium of smokers compared to nonsmokers [94]. The 
same study observed that the expression of miR-1246 is 
downregulated in the cells of smokers compared with 
nonsmokers, suggesting that miR-1246 plays a role in the 
regulation of ACE2, thus shedding light at the 
pathogenesis of COVID-19 and risk factors in the 
population. On the other hand, it was reported that 
curcumin can increase the expression of this miRNAs in 
endothelial cells [85]. This could suggest that 
consumption of curcumin would increase the expression 
of hsa-miR-1246, lower ACE2 levels and consequently 
the SARS-CoV-2 infection. It was also reported that 
human alveolar basal epithelial cells infected with 
influenza A viruses can modulate the expression of 20 
miRNA, including up-regulation of miR-1290 [95]. When 
miR-1290 antagonist, LNA-1290 is administrated to the 
cells, there is significant reduction of viral protein levels 
and viral titers [96]. Interestingly, we have described that 
flavanols can decrease the expression of this miRNA in 
endothelial cells [84]. Several studies also suggested the 
role of miR-21-3p in viral infection. For example, in A549 
cells, miR-21-3p promoted replication of influenza A 
virus [97]. Infection of A549 cells with influenza A virus 
(H1N1 or H5N1) in the presence of miR-21-3p inhibitor 
significantly decreased the viral load in the cells probably 
through regulation of HDAC8. On the other hand, in A549 
cells exposed to curcumin, a significant down-regulation 
in the expression of this gene has been identified [77]. 
Potential role in viral and/or antiviral properties have been 
described for few other common miRNAs, such as let-7a-
3p [98], miR-125a-5p [99] or miR-455-3p [100]. 
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Together with literature analysis, we also performed 
bioinformatic analysis to identify potential target genes of 
these 17 common miRNAs. Using MirWalk database 
(http://mirwalk.umm.uni-heidelberg.de) [101] we 
identified 1734 potential targets with minimum free 
energy <-20kcal/mol indicating a stronger predicted 
pairing between the miRNA and the target mRNA. With 
the aim to identify potential pathways in which these 
target genes are involved in we performed pathway 
analysis using MirWalk database as well as GeneTrail2 
database. Interestingly, both databases showed that the 
potential target genes are involved in different cellular 
pathways, including those that have been previously 
identified as involved in regulation of SARS-CoV-2 
replication [56]. These pathways include EGFR signaling, 
focal adhesion kinase, integrin signaling, mTOR 
signaling, p38 MAPK signaling, PDGF receptor-like 
signaling, PI3K-Akt signaling and VEGF signaling, 
described to regulate entry of the virus, its efficient 
replication, inflammatory responses or viral survival in 
infected cells (Fig. 2). Moreover, comparison of the target 
genes with genomic data present in databases using 
Enrichr tool (https://maayanlab.cloud/Enrichr/) [102] 
revealed significant homology with gene expression of 
healthy lung biopsy vs. SARS-CoV-2 infected lung, 
SARS-CoV-2 infection in lung tissue or A549 infected 
with SARS-CoV-2. Therefore, from the data on the effect 
of polyphenols on expression of miRNAs which 
potentially can target the SARS-CoV-2 genome as well as 
their potential targets, it could be suggested that these 
bioactives modulate expression of miRNAs in the host 
cells in such a way to prevent viral entry, its replication 
and survival, thus preventing or lowering the risk of 
development of complications in COVID-19. 
 
 
Figure 2.  Network between 17 miRNAs, common between cellular miRNAs than can interact with SARS-
CoV-2 RNA and miRNAs modulated by polyphenols, and their potential target genes. Blue circles represent 
miRNA, red circles are their potential targets. In yellow are target genes involved in pathways regulating virus entry, 
replication and viral infections. 
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The role of host miRNAs in viral infection, both pro-viral 
and antiviral properties, have been little described, 
particularly for SARS-CoV-2. Nevertheless, the existing 
knowledge described in this paper can provide solid bases 
to support the hypothesis that polyphenols can have 
protective properties against SARS-CoV-2 by modulating 
the expression of miRNAs of the host cells, hypothesis 
that can be corroborated with few studies that suggested 
that these bioactives can interact with ACE2 or other 
proteins involved in COVID-19 (Fig. 3). It is therefore 
urgent to develop studies to assess their capacity to 
prevent COVID-19 complications, such as in vitro studies 
with alveolar and endothelial cells, animal studies with 
SARS-CoV-2 infection along with diets supplemented 
with polyphenols. It is primordially important also to 
evaluate correlation between intake of polyphenols by the 
population and the incidence of COVID-19. Such study 
will provide direct demonstration of the impact of 
polyphenols on prevention of SARS-CoV-2 infection and 
development of complications. 
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